The Rheumatologist
COVID-19 NewsACR Convergence
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Gout Resource Center
      • Axial Spondyloarthritis Resource Center
      • Psoriatic Arthritis
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Case Report: Digital Ulcers & Weight Loss in a Pediatric Patient

Case Report: Digital Ulcers & Weight Loss in a Pediatric Patient

June 13, 2021 • By Anusha Vuppala, MD, & Sarwat Umer, MD

  • Tweet
  • Email
Print-Friendly Version / Save PDF

Juvenile dermatomyositis (JDM) is a childhood form of inflammatory myopathy affecting children younger than 18 years. The diagnosis of JDM is based on characteristic clinical features of proximal muscle weakness, skin rash, elevated muscle enzymes, magnetic resonance imaging and muscle biopsy.1

You Might Also Like
  • Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition
  • Case Report: Rapidly Progressive Interstitial Lung Disease in a 6-Year-Old
  • Case Report: A Patient with Clinically Amyotrophic Dermatomyositis & Associated ILD & RA Overlap
Explore This Issue
June 2021

Autoantibodies seen in patients with inflammatory myopathy are not only associated with particular phenotypes but also help determine the prognosis and risk of internal organ involvement.2 These antibodies are very rare in childhood myopathies.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

We describe an atypical case of pediatric JDM associated with rapidly progressive interstitial lung disease (RP-ILD).

Case Description

A 12-year-old Black, male patient with a past medical history of atopic dermatitis presented to us with swelling in both hands, a condition that had persisted for five months. Following a countryside visit to south Louisiana, a bumpy rash developed on his hands, which was followed by swelling. He was treated with permethrin for possible scabies by his primary care physician at the onset of the rash.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Because the rash did not improve, he was referred to a dermatologist. A skin biopsy, according to his mother, was unremarkable. The swelling gradually worsened over the next two months, and his mother noticed a new development—ulcers on his fingers (see Figure 1).

He was then referred to a rheuma­tol­ogist. On examination, he had swelling of the metacarpophalangeal and proximal interphalangeal joints, ulcers at the tips of his fingers and swelling of both ankle joints. Nailfold capillaroscopy was unremarkable. His strength was 4/5 in both upper arms. The laboratory results are in Table 1. He tested negative for anti-nuclear antibodies, anti-Scl 70 antibodies and anti-topoisomerase antibodies.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE
Figure 1: A 12-year-old Black male presented with digital ulcers and swelling.

Figure 1: A 12-year-old Black male presented with digital ulcers and swelling.

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

Figure 2: High-resolution computed tomography showed evidence of interstitial lung disease.

We initially thought he had systemic sclerosis. However, the lack of antibodies made diagnosis challenging. Due to lack of autoantibodies, but with muscle enzyme elevation and coexisting clinical weakness, myositis was the main diagnostic consideration.

We started treatment with 40 mg of prednisone and 10 mg of oral methotrexate (later increased to 20 mg) for myositis. Due to minimal improvement in his skin ulcers, we changed the methotrexate to a subcutaneous form at the increased dosage. However, the patient developed worsening dyspnea on exertion within a few months.

High-resolution computed tomography showed evidence of interstitial lung disease (see Figure 2). A test for anti-melanoma differentiation-associated protein 5 (MDA-5) antibody was ordered due to a high clinical suspicion of ILD. The results were positive. He was initiated on 250 mg of mycophenolate mofetil twice daily (note: 300 mg/m2, lower than the ideal 600 mg/m2 dose due to leukopenia) and 1 g/kg of intravenous immunoglobulin monthly for four doses, with significant improvement in weakness, ulcers and shortness of breath.

Table 1: Laboratory Results

TESTRESULT
ANANegative
Anti-Scl 70 antibody and anti-centromere antibodyNegative
Anti-Jo1 antibodyNegative
Anti-SSA 52 antibodyNegative
AST (aspartate aminotransferase)136 U/L (reference range [RR]: 15–37 U/L)
ALT (alanine aminotransferase)150 U/L (RR: 12–78 U/L)
Aldolase8.8 U/L (RR: 3.1–8.6 U/L)
Erythrocyte sedimentation rate (ESR)21 mm/hour (RR: 5–15 mm/hour)
Creatinine kinase79 mg/dL (RR: 26–308 mg/dL)
LD (lactate dehydrogenase)351 U/L (RR: 87–241 U/L)

Discussion

Juvenile dermatomyositis is a rare auto­immune disease characterized by vasculopathy, proximal muscle weakness and pathognomonic rash. Anti-MDA-5 antibody was originally described in a subset of patients with dermato­myositis whose disease was manifested only on skin for prolonged periods of time without muscle weakness.3 The role of anti-MDA-5 antibody in dermatomyositis is not clearly known. It is thought that antibody production occurs during viral infection of skin and lung epithelium.4 Its formation is triggered by release of MDA-5 from infected cells and is believed to injure endothelial cells and other tissues.

The incidence of myositis-specific antibodies in JDM is 10%, with a prevalence of anti-MDA-5 antibody of 7.4%.5 Anti-MDA-5 antibody is associated with clinically amyopathic or hypomyopathic dermatomyositis, ischemic cutaneous ulcerations, rapidly progressive ILD and a poor prognosis. The presentation is well described in the adult population, whereas it is very rare in the pediatric population.

Rheumatologists need to be aware of anti-MDA-5 antibody-associated RP-ILD in patients with juvenile dermatomyositis, the aggressive nature of the disease and the early, intense immunosuppression needed for a favorable prognosis.

Pages: 1 2 | Single Page

Filed Under: Conditions Tagged With: case report, interstitial lung disease (ILD), juvenile dermatomyositis, PediatricIssue: June 2021

You Might Also Like:
  • Fellow’s Forum Case Report: Arthritis, Fever, and Weight Loss In a Teenager Suggest A Rheumatic Condition
  • Case Report: Rapidly Progressive Interstitial Lung Disease in a 6-Year-Old
  • Case Report: A Patient with Clinically Amyotrophic Dermatomyositis & Associated ILD & RA Overlap
  • Case Report: Mycosis Fungoides in Dermatomyositis

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

American College of Rheumatology

Visit the official website for the American College of Rheumatology.

Visit the ACR »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use / Cookie Preferences

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2023 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)